secwatch.observer — SEC 8-K summary
======================================

Issuer:     iSpecimen Inc. (ISPC)
CIK:        0001558569
Form:       8-K
Filed at:   2024-12-12T23:59:59+00:00
Accession:  0001104659-24-128084
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

iSpecimen appoints Robert Lim as CEO and director effective Dec. 9, 2024
------------------------------------------------------------------------

- Robert Lim appointed CEO and board member; will provide strategic leadership and advisory services.
- Annual fee of $270,000 payable to Lim's personal corporation, 1513932 B.C. Ltd., in monthly installments.
- Lim is principal and co-founder of De Novo Law Corporation; brings legal, marketing, and business experience.
- No familial relationships with other directors/officers; no reportable legal proceedings in past 10 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1558569/000110465924128084/0001104659-24-128084-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1558569/000110465924128084/tm2430967d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-128084

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer